Skip to main content
. Author manuscript; available in PMC: 2011 Jun 1.
Published in final edited form as: FEMS Immunol Med Microbiol. 2010 Feb 17;59(1):71–80. doi: 10.1111/j.1574-695X.2010.00663.x

Table 2.

In vitro T cell priming assay:

Group
IFN-γ(pg/ml)
IL-2 (pg/ml)
Wild-type DCs + T cells 48.0 ± 4.8 33.7 ± 5.7
TCRδ−/− DCs + T cells 43.3 ± 3.2 33.3 ± 5.8
CD4+ T cells + OVA 33.3 ± 8.4 33.3 ± 2.6
Wild-type DCs + OVA + CD4+ T cells 31,242 ± 1623 18,953 ± 759
TCRδ−/− DCs + OVA + CD4+ T cells 21,640 ± 835** 16,543 ± 392*

Purified naïve CD4+ T cells from OT II transgenic mice were co-cultured with DCs from WNV-infected wild-type or TCRδ−/ − mice in the presence or absence of OVA 323–339. At 24 h post coculture, supernatant was harvested and measured for cytokine production using mouse Th1/Th2 cytokine kit. Data are presented as means ± SEM, n = 3.

*

P < 0.05 or

**

P < 0.01 for wild-type vs. TCRδ−/ −.

P values were calculated with a non-paired Student’st test. Data shown were representative of two independent experiments.